HER2-targeted regimens after prior trastuzumab for patients with HER2-positive unresectable, locally advanced or metastatic breast cancer: a network meta-analysis of randomized controlled trials
@article{ATM58671, author = {Xinghui Li and Songwen Wu and Lijie Zhang and Ji Zhu and Binghe Xu}, title = {HER2-targeted regimens after prior trastuzumab for patients with HER2-positive unresectable, locally advanced or metastatic breast cancer: a network meta-analysis of randomized controlled trials}, journal = {Annals of Translational Medicine}, volume = {8}, number = {24}, year = {2020}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/58671} }